Skip to main content

Sathyanarayanan Sriram's Form 4 filing

Codiak BioSciences, Inc.CDAK · filed Feb 21, 2023

Accession no.
0000899243-23-005694
Filed
Feb 21, 2023
Trade date
Aug 16, 2022-Feb 17, 2023
Filing delay
189 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.47K. It was filed 189 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sathyanarayanan SriramCIK 0001867898Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2022Common StockMOption exerciseAcquired+7,350–F1–9,102Direct
Aug 17, 2022Common StockSSaleDisposed−2,283$2.21−$5,045.436,819Direct
Feb 16, 2023Common StockMOption exerciseAcquired+7,350–F1–14,169Direct
Feb 17, 2023Common StockSSaleDisposed−2,407$0.59−$1,420.1311,762Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 16, 2022Common StockMOption exerciseDisposed−7,350$0.00$022,050Direct
Feb 16, 2023Common StockMOption exerciseDisposed−7,350$0.00$014,700Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)